Paid Clinical Trials in Arlington, VA
As of August 2026, 33 paid clinical trials are recruiting in Arlington, Virginia. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Arlington offers studies at sites including Virginia Cancer Specialists, PC for conditions such as Obesity, Colorectal Neoplasms, Alzheimers Disease, Overweight. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Arlington
Trials by drug in Arlington
Filter results
Newly added in Arlington
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
27 clinical trials
A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation
Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
Video-Based Patient Navigation to Support Cervical Cancer Screening Among Black Women
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
Top Research Study Locations in Arlington
Researchers run research studies in Arlington, VA at 19 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Cancer Specialists, PC | Breast Cancer, Breast Neoplasms, Colonic Diseases | 4 |
| Virginia Cancer Specialists | Colorectal Neoplasms, Non-small Cell Lung Cancer (NSCLC) | 3 |
| SkinDC | Moderate to Severe Glabellar Lines, Acne Scars, Mid Face Volume Deficit | 3 |
| Sana Research, LLC | Alzheimers Disease | 2 |
| Washington Cntr Weight Mgmt | Obesity, Overweight | 2 |
| Care Access - Arlington | Dermatitis Atopic | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Conquest Research, LLC | Heart Failure With Mildly Reduced Ejection Fraction, Heart Failure With Preserved Ejection Fraction, Obesity | 1 |
| HealthQare Associates | Diabetes, End Stage Renal Disease | 1 |
| ISA Associates | Uterine Cervical Neoplasms | 1 |
| Investigational | Subcutaneous Fat | 1 |
| Local Institution - 007-814-D | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 1241 | Psychosis Associated With Alzheimer's Disease | 1 |
| Panoramic Health - Virginia Nephrology Group | Kidney Disease | 1 |
| RAND | Birth, Maternal Health, Pregnancy | 1 |
| Virginia Cancer Specialists - Arlington | Non-small Cell Lung Cancer | 1 |
| Virginia Nephrology | Focal Segmental Glomerulosclerosis | 1 |
| Virginia Nephrology Group | Chronic Kidney Disease | 1 |
| Washington Center for Weight Management and Research | Body Weight, Nutrition Disorders, Nutritional and Metabolic Diseases | 1 |
Active & Upcoming Studies in Arlington (2026)
Recruiting trials in Arlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (8 active studies)
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
- A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation · Phase 3 · Astellas Pharma Global Development, Inc.
Diabetes & metabolic (6 active studies)
- AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight · Phase 3 · Novo Nordisk A/S
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Cardiovascular (4 active studies)
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF · Phase 3 · AstraZeneca
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Common conditions studied in Arlington
- Obesity (4 active studies)
- Colorectal Neoplasms (3 active studies)
- Alzheimers Disease (2 active studies)
- Overweight (2 active studies)
- Acne Scars (1 active study)
- Advanced Non-Small Cell Lung Cancer (1 active study)
Leading research sponsors in Arlington
- AstraZeneca
- Pfizer
- AbbVie
- Hoffmann-La Roche
- Janssen Research & Development, LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Arlington?
There are approximately 33 recruiting clinical trials in Arlington, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Arlington pay participants?
Most recruiting trials in Arlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Arlington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Arlington?
The most common conditions under active study in Arlington include Obesity (4), Colorectal Neoplasms (3), Alzheimers Disease (2), Overweight (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Arlington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Arlington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Arlington?
Recruiting research sites in Arlington include Virginia Cancer Specialists, PC, Virginia Cancer Specialists, SkinDC, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Arlington right now?
The largest active categories in Arlington are Cancer & tumors (8), Diabetes & metabolic (6), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.